Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Apolipoprotein A1-Mangel

Der Apolipoprotein A1-Mangel ist laborchemisch anhand des Fehlens dieses Proteins im Plasma nachweisbar. Klinisch besteht eine Hypoalphalipoproteinämie mit einem entsprechend erhöhten Risiko für arteriosklerotische Gefäßerkrankungen.

Gliederung

Apolipoprotein-Mangel
APOA5
APOB
APOC1
APOC2
APOC3
APOE
APOL1
APOM
Apolipoprotein A1-Mangel
APOA1
Apolipoprotein A2-Mangel
Apolipoprotein F-Mangel
Apolipoprotein H-Mangel
CLU

Referenzen:

1.

Karathanasis SK et al. () Linkage of human apolipoproteins A-I and C-III genes.

external link
2.

Protter AA et al. (1984) Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes.

external link
3.

Rall SC et al. (1984) Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.

external link
4.

Law SW et al. (1984) Human apolipoprotein A-I and C-III genes reside in the p11----q13 region of chromosome 11.

external link
5.

Cheung P et al. (1984) Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11.

external link
6.

Karathanasis SK et al. (1983) Isolation and characterization of the human apolipoprotein A-I gene.

external link
7.

Schamaun O et al. (1983) Genetic studies of an apoA-I lipoprotein variant.

external link
8.

O'Donnell KA et al. (1983) Genetic evidence that the multiple apolipoprotein A-1 isoforms are encoded by a common structural gene.

external link
9.

Shoulders CC et al. (1983) Gene structure of human apolipoprotein A1.

external link
10.

Law SW et al. (1983) cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.

external link
11.

Karathanasis SK et al. (1983) An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis.

external link
12.

Weisgraber KH et al. (1983) Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.

external link
13.

Utermann G et al. (1984) Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.

external link
14.

Breslow JL et al. (1982) Isolation and characterization of cDNA clones for human apolipoprotein A-I.

external link
15.

Botstein D et al. (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

external link
16.

Law SW et al. (1984) Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.

external link
17.

Rees A et al. (1983) DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia.

external link
18.

Miller GJ et al. (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

external link
19.

Borecki IB et al. (1986) A major gene for primary hypoalphalipoproteinemia.

external link
20.

Buraczynska M et al. (1985) Apolipoprotein A-I gene polymorphism and susceptibility of non-insulin-dependent diabetes mellitus.

external link
21.

Gualandri V et al. (1985) AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission.

external link
22.

Rall SC et al. (1986) Identification of homozygosity for a human apolipoprotein A-I variant.

external link
23.

Nichols WC et al. (1988) Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.

external link
24.

Fager G et al. () Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.

external link
25.

Yamakawa-Kobayashi K et al. (1999) Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey.

external link
26.

Hamidi Asl L et al. (1999) Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1.

external link
27.

Genschel J et al. (1998) Apolipoprotein A-I induced amyloidosis.

external link
28.

Huang W et al. (1998) A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.

external link
29.

Naganawa S et al. (1997) Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.

external link
30.

Dallinga-Thie GM et al. (1997) Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

external link
31.

Booth DR et al. (1996) Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.

external link
32.

Plump AS et al. (1996) Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production.

external link
33.

Ng DS et al. (1994) Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

external link
34.

Nakata K et al. (1993) Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene.

external link
35.

Franceschini G et al. (1980) A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.

external link
36.

Lusis AJ et al. (1983) Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins.

external link
37.

Vergani C et al. (1981) Familial hypo-alpha-lipoproteinemia.

external link
38.

Utermann G et al. (1982) Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation.

external link
39.

Daniels SR et al. () Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke.

external link
40.

Norum RA et al. (1982) Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease.

external link
41.

Glueck CJ et al. (1982) Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities.

external link
42.

Utermann G et al. (1982) Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI.

external link
43.

Schaefer EJ et al. () Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.

external link
44.

Weisgraber KH et al. (1980) A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.

external link
45.

Third JL et al. (1984) Primary and familial hypoalphalipoproteinemia.

external link
46.

Forte TM et al. (1984) Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.

external link
47.

Smith JD et al. (1992) Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro.

external link
48.

Ordovas JM et al. (1989) Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11.

external link
49.

Moll PP et al. (1989) Genetic determination of plasma apolipoprotein AI in a population-based sample.

external link
50.

Gustafson A et al. (1979) Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency.

external link
51.

Nichols WC et al. (1990) A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.

external link
52.

Ladias JA et al. (1990) Apolipoprotein A1 Baltimore (Arg10----Leu), a new ApoA1 variant.

external link
53.

Brewer HB et al. (1978) The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins.

external link
54.

Arinami T et al. (1990) Assignment of the apolipoprotein A-I gene to 11q23 based on RFLP in a case with a partial deletion of chromosome 11, del(11)(q23.3----qter).

external link
55.

Kastelein JJ et al. (1990) The gene causing familial hypoalphalipoproteinemia is not caused by a defect in the apo AI-CIII-AIV gene cluster in a Spanish family.

external link
56.

Matsunaga T et al. (1991) Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene.

external link
57.

Funke H et al. (1991) A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

external link
58.

Ajees AA et al. (2006) Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.

external link
59.

Bojanovski D et al. (1987) In vivo metabolism of proapolipoprotein A-I in Tangier disease.

external link
60.

Soutar AK et al. (1992) Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.

external link
61.

Nissen SE et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

external link
62.

Zhang Y et al. (2003) Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.

external link
63.

Martinez LO et al. (2003) Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis.

external link
64.

Sadaf A et al. (2002) Apolipoprotein AI promoter variant in blood pressure determination.

external link
65.

Shah PK et al. (2001) High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.

external link
66.

Obici L et al. (1999) The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.

external link
67.

Hamidi Asl K et al. (1999) A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis.

external link
68.

Lachmann HJ et al. (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

external link
69.

Kessling AM et al. (1988) DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high-density-lipoprotein cholesterol concentration.

external link
70.

Ferns GA et al. (1985) Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction.

external link
71.

Strobl W et al. (1988) Apolipoprotein A-I (Glu 198----Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia.

external link
72.

Karathanasis SK et al. (1987) DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis.

external link
73.

Schroeder WT et al. (1987) Localization of the human catalase and apolipoprotein A-I genes to chromosome 11.

external link
74.

Karathanasis SK et al. (1986) Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4).

external link
75.

Ginsberg HN et al. (1986) Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

external link
76.

Moll PP et al. (1986) The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: a study of high-risk pedigrees.

external link
77.

Ordovas JM et al. (1986) Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.

external link
78.

Rees A et al. (1986) Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population.

external link
79.

Yui Y et al. (1988) Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

external link
80.

Haddad IA et al. (1986) Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes.

external link
81.

Cohen T et al. (1986) DNA polymorphic sites in the human ApoAI-CIII-AIV cluster: Taq I and Ava I.

external link
82.

Frossard PM et al. (1986) ApaI RFLP 5.4 kb 5' to the human apolipoprotein AI (APO A1) gene.

external link
83.

Kessling AM et al. (1985) A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals.

external link
84.

Rees A et al. (1985) Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia.

external link
85.

Antonarakis SE et al. (1988) DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster.

external link
86.

Thompson EA et al. (1988) The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes.

external link
87.

None (1988) Apolipoprotein genetic variation and human disease.

external link
88.

Stocks J et al. (1987) Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia.

external link
89.

Hayden MR et al. (1987) DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.

external link
90.

Ferns GA et al. (1986) A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia.

external link
91.

von Eckardstein A et al. (1989) Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

external link
92.

OMIM.ORG article

Omim 107680 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz